Press releases
- IM Cannabis Reports First Quarter Financial Results
- IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET
- IMC to transfer its Oranim Pharmacy shares back to the seller
- IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
- Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
- IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients
- IM Cannabis Reports 2023 Financial Results
- IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization
- IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET
- IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company
More ▼
Key statistics
On Tuesday, IM Cannabis Corp (IMCC:NAQ) closed at 0.6349, 235.93% above the 52 week low of 0.189 set on Jan 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.662 |
---|---|
High | 0.68 |
Low | 0.6222 |
Bid | 0.6349 |
Offer | 0.6527 |
Previous close | 0.6675 |
Average volume | 483.07k |
---|---|
Shares outstanding | 13.39m |
Free float | 8.59m |
P/E (TTM) | -- |
Market cap | 12.72m CAD |
EPS (TTM) | -1.09 CAD |
Data delayed at least 15 minutes, as of May 21 2024 21:00 BST.
More ▼